Advertisement
Advertisement
IMCR
Immunocore Holdings plc - ADR
28.95
USDSponsored
-0.35
-1.19%
May 13, 16:00 UTC -4
Closed
Pre-Market
29.04
+0.09
+0.29%
IMCR Earnings Reports
Positive Surprise Ratio
IMCR beat 13 of 22 last estimates.
59%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$112.53M
/-$0.16
Implied change from Q1 26 (Revenue/ EPS)
+5.49%
/-164.00%
Implied change from Q2 25 (Revenue/ EPS)
+14.87%
/-20.00%
Immunocore Holdings plc - ADR earnings per share and revenue
On May 06, 2026, IMCR reported earnings of 0.25 USD per share (EPS) for Q1 26, beating the estimate of -0.26 USD, resulting in a 193.08% surprise. Revenue reached 106.68 million, compared to an expected 109.89 million, with a -2.92% difference. The market reacted with a +1.12% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 12 analysts forecast an EPS of -0.16 USD, with revenue projected to reach 112.53 million USD, implying an decrease of -164.00% EPS, and increase of 5.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kamada Ltd
Report Date
May 13, 2026 For Q1 26
Estimate
$0.11
Actual
$0.07
Surprise
-40.32%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Spero Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Equillium, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-34.53%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Tango Therapeutics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.32
Surprise
-0.13%
Longeveron Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.19
Surprise
-12.89%
Bionano Genomics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.96
Actual
-$0.76
Surprise
+21.57%
FAQ
What were Immunocore Holdings plc - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Immunocore Holdings plc - ADR reported EPS of $0.25, beating estimates by 193.08%, and revenue of $106.68M, -2.92% below expectations.
How did the market react to Immunocore Holdings plc - ADR's Q1 2026 earnings?
The stock price moved up 1.12%, changed from $28.52 before the earnings release to $28.84 the day after.
When is Immunocore Holdings plc - ADR expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Immunocore Holdings plc - ADR's next earnings report?
Based on 12
analysts, Immunocore Holdings plc - ADR is expected to report EPS of -$0.16 and revenue of $112.53M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement